Raymond James Financial Services Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.38M | Sell |
15,379
-248
| -2% | -$22.3K | ﹤0.01% | 1948 |
|
|
2024
Q2 | $1.26M | Sell |
15,627
-1,694
| -10% | -$136K | ﹤0.01% | 1944 |
|
|
2024
Q1 | $1.38M | Sell |
17,321
-815
| -4% | -$65K | ﹤0.01% | 1861 |
|
|
2023
Q4 | $1.44M | Sell |
18,136
-598
| -3% | -$47.6K | ﹤0.01% | 1751 |
|
|
2023
Q3 | $1.31M | Buy |
18,734
+197
| +1% | +$13.8K | ﹤0.01% | 1760 |
|
|
2023
Q2 | $1.33M | Buy |
18,537
+1,744
| +10% | +$125K | ﹤0.01% | 1763 |
|
|
2023
Q1 | $1.04M | Buy |
16,793
+361
| +2% | +$22.3K | ﹤0.01% | 1874 |
|
|
2022
Q4 | $1.27M | Buy |
16,432
+490
| +3% | +$37.8K | ﹤0.01% | 1693 |
|
|
2022
Q3 | $711K | Sell |
15,942
-1,750
| -10% | -$78K | ﹤0.01% | 2042 |
|
|
2022
Q2 | $678K | Hold |
17,692
| – | – | ﹤0.01% | 2082 |
|
|
2022
Q1 | $732K | Buy |
+17,692
| New | +$732K | ﹤0.01% | 2148 |
|